Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 3:10:574417.
doi: 10.3389/fcimb.2020.574417. eCollection 2020.

Mobilization and Activation of the Innate Immune Response to Dengue Virus

Christine A King  1 , Adam D Wegman  1 , Timothy P Endy  1
Affiliations
Review

Mobilization and Activation of the Innate Immune Response to Dengue Virus

Christine A King et al. Front Cell Infect Microbiol. .

Abstract

Dengue virus is an important human pathogen, infecting an estimated 400 million individuals per year and causing symptomatic disease in a subset of approximately 100 million. Much of the effort to date describing the host response to dengue has focused on the adaptive immune response, in part because of the well-established roles of antibody-dependent enhancement and T cell original sin as drivers of severe dengue upon heterotypic secondary infection. However, the innate immune system is a crucial factor in the host response to dengue, as it both governs the fate and vigor of the adaptive immune response, and mediates the acute inflammatory response in tissues. In this review, we discuss the innate inflammatory response to dengue infection, focusing on the role of evolutionarily conserved innate immune cells, their effector functions, and clinical course.

Keywords: clinical symptoms; dengue; inflammation; innate immunity; interferon; macrophages; mast cells; pathogenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Path of dengue infection from mosquito bite to dissemination to organs. Created with Biorender.com.
Figure 2
Figure 2
Dengue subversion of interferon signaling. Created with Biorender.com.
See this image and copyright information in PMC

References

    1. Abraham S. N., Malaviya R. (1997). Mast cells in infection and immunity. Infect. Immun. 65 (9), 3501–3508. 10.1128/IAI.65.9.3501-3508.1997 - DOI - PMC - PubMed
    1. Abraham S. N., St John A. L. (2010). Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10 (6), 440–452. 10.1038/nri2782 - DOI - PMC - PubMed
    1. Afrin L. B., Self S., Menk J., Lazarchick J. (2017). Characterization of Mast Cell Activation Syndrome. Am. J. Med. Sci. 353 (3), 207–215. 10.1016/j.amjms.2016.12.013 - DOI - PMC - PubMed
    1. Ahmad A., Waseem T., Butt N. F., Randhawa F. A., Malik U., Shakoori T. A. (2018). Montelukast reduces the risk of dengue shock syndrome in dengue patienys. Trop. Biomed. 35 (4), 1115–1122. - PubMed
    1. Alvarez Y., Valera I., Municio C., Hugo E., Padron F., Blanco L., et al. (2010). Eicosanoids in the innate immune response: TLR and non-TLR routes. Mediators Inflamm. 2010, 1–14. 10.1155/2010/201929 - DOI - PMC - PubMed